New vaccine support (NVS) for IPV
GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems.
- ID Projet
47122-1518-UGA-25B-X
- Statut de l'activité
- 2 - Implementation
- Type d'aide
- B02 - Contributions aux budgets réguliers des institutions multilatérales
- % to Ouganda
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
- Extending
- United Nations Childrens Fund
Versements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2018 |
Q2 |
1,847,220.00 |
1,847,220.00 |
2017 |
Q4 |
500,888.00 |
500,888.00 |
2017 |
Q3 |
516,847.00 |
516,847.00 |
2017 |
Q2 |
1,076,740.00 |
1,076,740.00 |
2017 |
Q1 |
406,200.00 |
406,200.00 |
2016 |
Q4 |
421,000.00 |
421,000.00 |
2016 |
Q3 |
356,142.00 |
356,142.00 |
2016 |
Q2 |
-110,759.00 |
-110,759.00 |
2016 |
Q1 |
862,000.00 |
862,000.00 |
2015 |
Q4 |
-115,900.00 |
-115,900.00 |
2015 |
Q3 |
111,062.00 |
111,062.00 |
2014 |
Q4 |
1,542,669.00 |
1,542,669.00 |
Engagements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2017 |
Q2 |
-708,595.00 |
-708,595.00 |
2016 |
Q2 |
-171,490.00 |
-171,490.00 |
2016 |
Q1 |
3,508,500.00 |
3,508,500.00 |
2014 |
Q3 |
5,922,000.00 |
5,922,000.00 |
Projections de CDMT par exercice fiscal
Exercice fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2017 |
1,428,750.00 |
1,428,750.00 |
2016 |
3,215,000.00 |
3,215,000.00 |
2015 |
2,961,000.00 |
2,961,000.00 |
2014 |
1,174,750.00 |
1,174,750.00 |
Code CRS |
% |
Lutte contre les maladies infectieuses
(12250)
|
100.0
|